This Phase 3 Trial has Shown Improved Overall Survival - Toxicity Profile has been stable with prolonged exposure to drugs
Keith Stewart, MD from Mayo Clinic Division of Hematology and Oncology discusses this phase 3 trial has shown improved overall survival and toxicity profile has been stable with prolonged exposure to ...
Author: ASHReport
Added: 01/23/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts